Literature DB >> 15542198

Sucrose fatty acid sulphate esters as novel vaccine adjuvants: effect of the chemical composition.

Anneke G Blom1, Luuk A Th Hilgers.   

Abstract

Adjuvant activity of novel, synthetic sucrose derivatives towards a recombinant glycoprotein was determined in large, non-rodent animal species. Compared to antigen alone, up to 3000-fold higher virus neutralizing antibody titres (VNTs) and 10-fold higher cellular responses against classical swine fever virus were observed in pigs after two immunizations with the sucrose derivatives combined with a squalane-in-water emulsion. The chemical composition of the derivative was crucial and sucrose esters containing one sulphate and seven dodecanoic (C12) or decanoic (C10) esters exerted the highest adjuvanticity. Derivatives without sulphate, with fewer fatty acid esters or with shorter or longer alkyl esters were less effective. Strong adjuvant activity of these formulations was the result of synergistic collaboration between the sucrose ester and the squalane emulsion, as factor of increase in VNT by the individual components was between 4 and 34. Enhanced humoral and cell-mediated immune responses lasted for at least 24 weeks. We concluded that combinations of hydrophobic, negatively-charged sucrose fatty acid sulphate esters plus submicron emulsions of squalane-in-water are strong adjuvants for humoral and cell-mediated immunity and that these formulations are promising adjuvants for future vaccines containing poor immunogens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542198     DOI: 10.1016/j.vaccine.2004.07.021

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.

Authors:  Madelon Q Wentink; Tilman M Hackeng; Sebastien P Tabruyn; Wouter C Puijk; Klaus Schwamborn; Daniele Altschuh; Rob H Meloen; Teun Schuurman; Arjan W Griffioen; Peter Timmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

2.  A single immunization with CoVaccine HT-adjuvanted H5N1 influenza virus vaccine induces protective cellular and humoral immune responses in ferrets.

Authors:  R Bodewes; J H C M Kreijtz; G van Amerongen; M M Geelhoed-Mieras; R J Verburgh; J G M Heldens; J Bedwell; J M A van den Brand; T Kuiken; C A van Baalen; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

3.  Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvant.

Authors:  Kendall B Preston; Teri Ann S Wong; Albert To; Taylor E Tashiro; Michael M Lieberman; Alex Granados; Karen Feliciano; John Harrison; Jake Yalley-Ogunro; Hanne Andersen Elyard; Oreola Donini; Axel T Lehrer; Theodore W Randolph
Journal:  Vaccine       Date:  2021-08-13       Impact factor: 4.169

4.  Generation of humoral immune responses to multi-allele PfAMA1 vaccines; effect of adjuvant and number of component alleles on the breadth of response.

Authors:  Kwadwo A Kusi; Bart W Faber; Vanessa Riasat; Alan W Thomas; Clemens H M Kocken; Edmond J Remarque
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

5.  Vaccination with Plasmodium knowlesi AMA1 formulated in the novel adjuvant co-vaccine HT™ protects against blood-stage challenge in rhesus macaques.

Authors:  Muzamil Mahdi Abdel Hamid; Edmond J Remarque; Leonie M van Duivenvoorde; Nicole van der Werff; Vanessa Walraven; Bart W Faber; Clemens H M Kocken; Alan W Thomas
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

6.  Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice.

Authors:  Albert To; Liana O Medina; Kenji O Mfuh; Michael M Lieberman; Teri Ann S Wong; Madhuri Namekar; Eileen Nakano; Chih-Yun Lai; Mukesh Kumar; Vivek R Nerurkar; Axel T Lehrer
Journal:  mSphere       Date:  2018-01-10       Impact factor: 4.389

Review 7.  Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research.

Authors:  Elena Mata; Aiala Salvador; Manoli Igartua; Rosa María Hernández; José Luis Pedraz
Journal:  Biomed Res Int       Date:  2013-04-23       Impact factor: 3.411

8.  An empirical approach towards the efficient and optimal production of influenza-neutralizing ovine polyclonal antibodies demonstrates that the novel adjuvant CoVaccine HT™ is functionally superior to Freund's adjuvant.

Authors:  Natalie E Stevens; Cara K Fraser; Mohammed Alsharifi; Michael P Brown; Kerrilyn R Diener; John D Hayball
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

9.  Murine leukemia virus p12 tethers the capsid-containing pre-integration complex to chromatin by binding directly to host nucleosomes in mitosis.

Authors:  Madushi Wanaguru; David J Barry; Donald J Benton; Nicola J O'Reilly; Kate N Bishop
Journal:  PLoS Pathog       Date:  2018-06-15       Impact factor: 6.823

Review 10.  Squalene emulsions for parenteral vaccine and drug delivery.

Authors:  Christopher B Fox
Journal:  Molecules       Date:  2009-09-01       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.